Sio Gene Therapies Inc. Research and Development Expense
Sio Gene Therapies Inc. reported Research and Development Expense of $1.88 million for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-02-14
- Sio Gene Therapies Inc. research and development expense for the quarter ending 2022-12-31 was $1.88M, a 91.15% decline year-over-year.
- Sio Gene Therapies Inc. research and development expense for the quarter ending 2022-09-30 was $336.00K, a 97.06% decline year-over-year.
- Sio Gene Therapies Inc. research and development expense for the quarter ending 2022-06-30 was $5.54M, a 31.22% decline year-over-year.
- Sio Gene Therapies Inc. research and development expense for the quarter ending 2022-03-31 was $12.61M, a 52.91% increase year-over-year.
- Sio Gene Therapies Inc. research and development expense for fiscal 2022 was $53.40M, a 114.43% increase from fiscal 2021.
- Sio Gene Therapies Inc. research and development expense for fiscal 2021 was $24.90M, a 47.14% decline from fiscal 2020.
- Sio Gene Therapies Inc. research and development expense for fiscal 2020 was $47.11M, a 46.19% decline from fiscal 2019.
- Sio Gene Therapies Inc. research and development expense for fiscal 2019 was $87.55M, a 38.09% decline from fiscal 2018.
| Period end | Research and Development Expense 2 month | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 5 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $1.88M 10-Q · filed 2023-02-14 | $2.22M derived: sum of 2 quarters · filed 2023-02-14 | $7.76M 10-Q · filed 2023-02-14 | $20.37M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2022-09-30 | $336.00K 10-Q · filed 2022-11-10 | $5.88M 10-Q · filed 2022-11-10 | $18.48M derived: sum of 3 quarters · filed 2022-11-10 | $39.77M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2022-06-30 | $5.54M 10-Q · filed 2022-08-11 | $18.15M derived: sum of 2 quarters · filed 2022-08-11 | $39.44M derived: sum of 3 quarters · filed 2023-02-14 | $50.88M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2022-03-31 | $12.61M 10-K · filed 2022-06-14 | $33.89M derived: sum of 2 quarters · filed 2023-02-14 | $45.34M derived: sum of 3 quarters · filed 2023-02-14 | $53.40M 10-K · filed 2022-06-14 | |||
| 2021-12-31 | $21.29M 10-Q · filed 2023-02-14 | $32.73M derived: sum of 2 quarters · filed 2023-02-14 | $40.79M 10-Q · filed 2023-02-14 | $49.04M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-09-30 | $11.45M 10-Q · filed 2022-11-10 | $19.51M 10-Q · filed 2022-11-10 | $27.75M derived: sum of 3 quarters · filed 2022-11-10 | $34.16M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $8.06M 10-Q · filed 2022-08-11 | $16.30M derived: sum of 2 quarters · filed 2022-08-11 | $22.71M derived: sum of 3 quarters · filed 2022-08-11 | $27.77M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $8.24M 10-K · filed 2022-06-14 | $14.65M derived: sum of 2 quarters · filed 2022-06-14 | $19.71M derived: sum of 3 quarters · filed 2022-06-14 | $24.90M 10-K · filed 2022-06-14 | |||
| 2020-12-31 | $6.41M 10-K · filed 2022-06-14 | $11.46M derived: sum of 2 quarters · filed 2022-06-14 | $16.66M 10-Q · filed 2022-02-11 | $27.58M derived: sum of 4 quarters · filed 2022-06-14 | |||
| 2020-09-30 | $5.06M 10-K · filed 2022-06-14 | $10.25M 10-Q · filed 2021-11-12 | $21.17M derived: sum of 3 quarters · filed 2022-06-14 | $29.44M derived: sum of 4 quarters · filed 2022-06-14 | |||
| 2020-06-30 | $5.19M 10-K · filed 2022-06-14 | $16.11M derived: sum of 2 quarters · filed 2022-06-14 | $24.38M derived: sum of 3 quarters · filed 2022-06-14 | $31.21M derived: sum of 4 quarters · filed 2022-06-14 | |||
| 2020-03-31 | $10.92M 10-K · filed 2021-06-09 | $19.19M derived: sum of 2 quarters · filed 2021-06-09 | $26.02M derived: sum of 3 quarters · filed 2021-06-09 | $47.11M 10-K · filed 2021-06-09 | |||
| 2019-12-31 | $8.27M 10-K · filed 2021-06-09 | $15.10M derived: sum of 2 quarters · filed 2021-06-09 | $36.19M 10-Q · filed 2021-02-09 | $43.34M derived: sum of 4 quarters · filed 2021-06-09 | |||
| 2019-09-30 | $6.83M 10-K · filed 2021-06-09 | $27.92M 10-Q · filed 2020-11-13 | $35.07M derived: sum of 3 quarters · filed 2021-06-09 | $56.55M derived: sum of 4 quarters · filed 2021-06-09 | |||
| 2019-06-30 | $21.09M 10-K · filed 2021-06-09 | $28.24M derived: sum of 2 quarters · filed 2021-06-09 | $49.72M derived: sum of 3 quarters · filed 2021-06-09 | $71.22M derived: sum of 4 quarters · filed 2021-06-09 | |||
| 2019-03-31 | $7.15M 10-K · filed 2020-06-10 | $28.63M derived: sum of 2 quarters · filed 2020-06-10 | $50.13M derived: sum of 3 quarters · filed 2020-06-10 | $87.55M 10-K · filed 2020-06-10 | |||
| 2018-12-31 | $21.48M 10-K · filed 2020-06-10 | $42.98M derived: sum of 2 quarters · filed 2020-06-10 | $80.40M 10-Q · filed 2020-02-10 | $102.20M derived: sum of 4 quarters · filed 2020-06-10 | |||
| 2018-09-30 | $21.50M 10-K · filed 2020-06-10 | $58.92M 10-Q · filed 2019-11-08 | $80.72M derived: sum of 3 quarters · filed 2020-06-10 | $118.06M derived: sum of 4 quarters · filed 2020-06-10 | |||
| 2018-06-30 | $37.42M 10-K · filed 2020-06-10 | $59.22M derived: sum of 2 quarters · filed 2020-06-10 | $96.56M derived: sum of 3 quarters · filed 2020-06-10 | $135.12M derived: sum of 4 quarters · filed 2020-06-10 | |||
| 2018-03-31 | $21.80M 10-K · filed 2019-06-11 | $59.15M derived: sum of 2 quarters · filed 2019-06-11 | $97.70M derived: sum of 3 quarters · filed 2019-06-11 | $141.41M 10-K · filed 2019-06-11 | |||
| 2017-12-31 | $37.35M 10-K · filed 2019-06-11 | $75.90M derived: sum of 2 quarters · filed 2019-06-11 | $119.61M 10-Q · filed 2019-02-07 | $160.41M derived: sum of 4 quarters · filed 2019-06-11 | |||
| 2017-09-30 | $38.55M 10-K · filed 2019-06-11 | $82.27M 10-Q · filed 2018-11-07 | $123.06M derived: sum of 3 quarters · filed 2019-06-11 | $159.69M derived: sum of 4 quarters · filed 2019-06-11 | |||
| 2017-06-30 | $43.71M 10-K · filed 2019-06-11 | $84.51M derived: sum of 2 quarters · filed 2019-06-11 | $121.14M derived: sum of 3 quarters · filed 2019-06-11 | $153.21M derived: sum of 4 quarters · filed 2019-06-11 | |||
| 2017-03-31 | $40.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-11 | $77.43M derived: sum of 2 quarters · filed 2018-06-11 | $109.50M derived: sum of 3 quarters · filed 2018-06-11 | $134.78M 10-K · filed 2018-06-11 | |||
| 2016-12-31 | $36.63M 10-Q · filed 2018-02-09 | $68.70M derived: sum of 2 quarters · filed 2018-02-09 | $93.98M 10-Q · filed 2018-02-09 | $117.42M derived: sum of 4 quarters · filed 2018-06-11 | |||
| 2016-09-30 | $32.07M 10-Q · filed 2017-11-02 | $57.35M 10-Q · filed 2017-11-02 | $80.78M derived: sum of 3 quarters · filed 2018-06-11 | $115.11M derived: sum of 4 quarters · filed 2018-06-11 | |||
| 2016-06-30 | $25.28M 10-Q · filed 2017-08-07 | $48.71M derived: sum of 2 quarters · filed 2018-06-11 | $83.03M derived: sum of 3 quarters · filed 2018-06-11 | $92.43M derived: sum of 4 quarters · filed 2018-06-11 | |||
| 2016-03-31 | $23.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-11 | $57.76M derived: sum of 2 quarters · filed 2018-06-11 | $67.16M derived: sum of 3 quarters · filed 2018-06-11 | $76.64M 10-K · filed 2018-06-11 | |||
| 2015-12-31 | $34.32M 10-Q · filed 2017-02-14 | $43.72M derived: sum of 2 quarters · filed 2017-02-14 | $53.21M 10-Q · filed 2017-02-14 | ||||
| 2015-09-30 | $9.40M 10-Q · filed 2016-11-07 | $8.28M 10-Q · filed 2015-11-02 | $18.89M 10-Q · filed 2016-11-07 | ||||
| 2015-06-30 | $9.49M 10-Q · filed 2016-08-15 | $10.61M 10-Q · filed 2015-08-11 | |||||
| 2015-03-31 | $14.32M 10-K · filed 2017-06-13 | ||||||
| 2014-12-31 | $10.54M 10-Q · filed 2016-02-09 |